A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients
2020 · Journal of Translational Medicine · 141 citations
https://doi.org/10.1186/s12967-020-02492-9
B
Bufu Tang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
145
Papers
2.8K
Citations
29
h-index
53
i10-index
Bufu Tang is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: Ferroptosis and cancer prognosis & Cancer Immunotherapy and Biomarkers & RNA modifications and cancer. The author has an h-index of 29, co-authored 124 publications.
ORCID: 0000-0003-3525-4433Papers by this author
worksSialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe3+ as a novel theranostic agent for T1/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer
2020 · Bioactive Materials · 113 citations
https://doi.org/10.1016/j.bioactmat.2020.10.020
Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope
2024 · Molecular Cancer · 92 citations
https://doi.org/10.1186/s12943-024-02130-8
Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma
2020 · Cell Communication and Signaling · 70 citations
https://doi.org/10.1186/s12964-020-00539-4
MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway
2018 · Scientific Reports · 56 citations
https://doi.org/10.1038/s41598-018-26381-w
xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade
2022 · Cell Death and Disease · 51 citations
https://doi.org/10.1038/s41419-022-04827-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat